Literature DB >> 8150096

International consensus conference on postmenopausal hormone therapy and the cardiovascular system.

R A Lobo, L Speroff.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8150096     DOI： 10.1016/s0015-0282(16)56630-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  4 in total

Review 1.  Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  R H Foster; J A Balfour
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.

Authors:  R K Bhathena; B S Anklesaria; A M Ganatra; R Pinto
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

3.  The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice.

Authors:  C Pendaries; B Darblade; P Rochaix; A Krust; P Chambon; K S Korach; F Bayard; J F Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production.

Authors:  J F Arnal; S Clamens; C Pechet; A Negre-Salvayre; C Allera; J P Girolami; R Salvayre; F Bayard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.